Four Moringa-Linked Salmonella Events in Four Months

Four Moringa-Linked Salmonella Events in Four Months: The Timeline That Should Not Exist

An MDP Consumer and Industry Brief

A single recall can be dismissed as a one-time failure. Two recalls in the same ingredient category raise questions. But when moringa-based products are repeatedly linked to Salmonella illnesses over the span of a few months, it becomes difficult to avoid a larger conclusion that this is no longer an isolated event. It is a pattern.

The Timeline (Late 2025 to February 2026)

Late 2025: The “Invisible Outbreak” Warning Sign

In late 2025, contaminated moringa powder revealed a key weakness in the U.S. supplement safety model: outbreaks may remain invisible until illnesses occur and investigators can link cases to a common exposure.

MDP previously documented this issue as an “invisible outbreak” problem, one that is especially concerning in widely distributed supplements.

January 15, 2026: Live it Up Super Greens Recall

Superfoods Inc. dba Live it Up recalled Live it Up Super Greens after an outbreak that sickened 45 people across multiple states, with 12+ hospitalizations.

This recall was widely reported and became one of the most visible supplement-linked Salmonella events in recent memory.

January 28, 2026: Why Not Natural Organic Moringa Recall

Why Not Natural (Houston, Texas) recalled its Why Not Natural Organic Moringa – Green Superfood capsules due to possible Salmonella contamination.

FDA noted that the potential contamination was identified as part of an ongoing outbreak investigation involving products that contain moringa as an ingredient.

February 13, 2026: Rosabella Moringa Capsules Recall

Ambrosia Brands, LLC (New York, New York) recalled certain lots of Rosabella Moringa Capsules due to possible Salmonella contamination.

The company reported 7 illnesses and 3 hospitalizations and noted that FDA and CDC reported the outbreak may be linked to Rosabella Moringa Capsules.

The Public Health Problem: Outbreaks Treated as Individual Events

From a public health perspective, what stands out is not only the number of events. It is the way they are handled. Each outbreak is treated as a separate incident. A recall notice, a CDC investigation page, a warning to consumers, and a request to avoid rumors.

But the recurring ingredient signal, moringa, has not yet been treated as a systemic risk requiring escalation across the supplement category.

In a risk-based safety system, repeat outbreaks trigger stronger preventive expectations. They do not remain “case-by-case” indefinitely.

The Bottom Line

Four moringa-linked Salmonella events in as many months should not be normal. And yet, under the current system, it is.

This is the timeline that should have triggered an escalation, because at this point moringa is no longer just an ingredient. It is a repeat-outbreak vehicle.

Next in this series

Story 2: Why These Outbreaks Keep Happening: “Illness First, Controls Later”